Clinical Trials on 良性気管支新生物 in Japan
合計3259件
-
Eli Lilly and Company完了
-
Eli Lilly and CompanyNippon Shinyaku Co., Ltd.完了
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, Japan完了
-
Kyoto UniversityTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japanわからない
-
Kyushu UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完了
-
Shiga UniversityUniversity of Chicago; Shionogi; Tokyo University; Showa University; Fukushima Medical University; Tohoku...わからない
-
Kyowa Kirin Co., Ltd.終了しました
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyoわからない
-
Tokyo UniversityShionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima Medical University; Kanagawa Cancer Center と他の協力者わからない
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyoわからない
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完了
-
Wakayama Medical UniversityMerck Sharp & Dohme LLCわからない
-
Kyowa Kirin Co., Ltd.完了
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完了
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完了
-
West Japan Thoracic Oncology Groupわからない
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完了
-
Bristol-Myers Squibb完了
-
National Hospital Organization Nagoya Medical CenterMerck Sharp & Dohme LLC; Central Japan Lung Study Group積極的、募集していない
-
Kobe City General Hospital終了しました
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd完了
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完了
-
Bristol-Myers SquibbOno Pharma USA Inc完了
-
Kyowa Kirin Co., Ltd.完了